Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

177 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Simvastatin is effective in killing the radioresistant breast carcinoma cells.
Aschenbrenner B, Negro G, Savic D, Sorokin M, Buzdin A, Ganswindt U, Cemazar M, Sersa G, Skvortsov S, Skvortsova I. Aschenbrenner B, et al. Among authors: ganswindt u. Radiol Oncol. 2021 May 4;55(3):305-316. doi: 10.2478/raon-2021-0020. Radiol Oncol. 2021. PMID: 33939900 Free PMC article.
Therapy resistance mediated by cancer stem cells.
Steinbichler TB, Dudás J, Skvortsov S, Ganswindt U, Riechelmann H, Skvortsova II. Steinbichler TB, et al. Among authors: ganswindt u. Semin Cancer Biol. 2018 Dec;53:156-167. doi: 10.1016/j.semcancer.2018.11.006. Epub 2018 Nov 22. Semin Cancer Biol. 2018. PMID: 30471331 Review.
Therapy resistance mediated by exosomes.
Steinbichler TB, Dudás J, Skvortsov S, Ganswindt U, Riechelmann H, Skvortsova II. Steinbichler TB, et al. Among authors: ganswindt u. Mol Cancer. 2019 Mar 30;18(1):58. doi: 10.1186/s12943-019-0970-x. Mol Cancer. 2019. PMID: 30925921 Free PMC article. Review.
Molecular heterogeneity in breast carcinoma cells with increased invasive capacities.
Negro G, Aschenbrenner B, Brezar SK, Cemazar M, Coer A, Gasljevic G, Savic D, Sorokin M, Buzdin A, Callari M, Kvitsaridze I, Jewett A, Vasileva-Slaveva M, Ganswindt U, Skvortsova I, Skvortsov S. Negro G, et al. Among authors: ganswindt u. Radiol Oncol. 2020 Feb 14;54(1):103-118. doi: 10.2478/raon-2020-0007. Radiol Oncol. 2020. PMID: 32061169 Free PMC article.
A prognostic mRNA expression signature of four 16q24.3 genes in radio(chemo)therapy-treated head and neck squamous cell carcinoma (HNSCC).
Wintergerst L, Selmansberger M, Maihoefer C, Schüttrumpf L, Walch A, Wilke C, Pitea A, Woischke C, Baumeister P, Kirchner T, Belka C, Ganswindt U, Zitzelsberger H, Unger K, Hess J. Wintergerst L, et al. Among authors: ganswindt u. Mol Oncol. 2018 Dec;12(12):2085-2101. doi: 10.1002/1878-0261.12388. Epub 2018 Oct 26. Mol Oncol. 2018. PMID: 30259648 Free PMC article.
The Role of Cancer Stem Cells in Radiation Resistance.
Arnold CR, Mangesius J, Skvortsova II, Ganswindt U. Arnold CR, et al. Among authors: ganswindt u. Front Oncol. 2020 Feb 20;10:164. doi: 10.3389/fonc.2020.00164. eCollection 2020. Front Oncol. 2020. PMID: 32154167 Free PMC article. Review.
Digital scoring of EpCAM and slug expression as prognostic markers in head and neck squamous cell carcinomas.
Schinke H, Heider T, Herkommer T, Simon F, Blancke Soares A, Kranz G, Samaga D, Dajka L, Feuchtinger A, Walch A, Valeanu L, Walz C, Kirchner T, Canis M, Baumeister P, Belka C, Maihöfer C, Marschner S, Pflugradt U, Ganswindt U, Hess J, Zitzelsberger H, Gires O. Schinke H, et al. Among authors: ganswindt u. Mol Oncol. 2021 Apr;15(4):1040-1053. doi: 10.1002/1878-0261.12886. Epub 2020 Dec 29. Mol Oncol. 2021. PMID: 33340247 Free PMC article.
Vinorelbine in bladder-preserving multimodality treatment for muscle-invasive bladder cancer-a valid option for cisplatin-unfit patients?
Arnold CR, Lindner AK, Schachtner G, Tulchiner G, Tulchiner N, Mangesius J, Maffei M, Horninger W, Kouvaiou O, Lukas P, Ganswindt U, Pichler R, Skvortsov S. Arnold CR, et al. Among authors: ganswindt u. Strahlenther Onkol. 2022 Jan;198(1):25-32. doi: 10.1007/s00066-021-01837-7. Epub 2021 Aug 19. Strahlenther Onkol. 2022. PMID: 34414475 Free PMC article.
HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).
Linge A, Lohaus F, Löck S, Nowak A, Gudziol V, Valentini C, von Neubeck C, Jütz M, Tinhofer I, Budach V, Sak A, Stuschke M, Balermpas P, Rödel C, Grosu AL, Abdollahi A, Debus J, Ganswindt U, Belka C, Pigorsch S, Combs SE, Mönnich D, Zips D, Buchholz F, Aust DE, Baretton GB, Thames HD, Dubrovska A, Alsner J, Overgaard J, Krause M, Baumann M; DKTK-ROG. Linge A, et al. Among authors: ganswindt u. Radiother Oncol. 2016 Dec;121(3):364-373. doi: 10.1016/j.radonc.2016.11.008. Epub 2016 Nov 29. Radiother Oncol. 2016. PMID: 27913065
177 results